Mesenchymal Stromal Cells in Ischemic Brain Injury
Ischemic brain injury represents a major cause of death worldwide with limited treatment options with a narrow therapeutic window. Accordingly, novel treatments that extend the treatment from the early neuroprotective stage to the late regenerative phase may accommodate a much larger number of strok...
Main Authors: | Beverly Brooks, Dominique Ebedes, Ahsan Usmani, Joaquin Vega Gonzales-Portillo, Daniel Gonzales-Portillo, Cesario V. Borlongan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/6/1013 |
Similar Items
-
Editorial: Current Progress in Mesenchymal Stem/Stromal Cell Research
by: Lindolfo da Silva Meirelles, et al.
Published: (2021-02-01) -
Combination of Stem Cells and Rehabilitation Therapies for Ischemic Stroke
by: Reed Berlet, et al.
Published: (2021-09-01) -
Mesenchymal Stromal Cells: Heterogeneity and Therapeutical Applications
by: Meryem Ouzin, et al.
Published: (2023-08-01) -
Mesenchymal stromal cell therapy in ischemic stroke
by: Zhang Y, et al.
Published: (2016-11-01) -
Mesenchymal Stromal/Stem cells: Historical perspective and ongoing challenges
by: Maria Isabel Doria Rossi, et al.
Published: (2020-06-01)